Does TIRBANIBULIN Cause Off label use? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Off label use have been filed in association with TIRBANIBULIN (Klisyri). This represents 5.6% of all adverse event reports for TIRBANIBULIN.
11
Reports of Off label use with TIRBANIBULIN
5.6%
of all TIRBANIBULIN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Off label use From TIRBANIBULIN?
Of the 11 reports.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIRBANIBULIN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does TIRBANIBULIN Cause?
Drug ineffective (44)
Application site erythema (31)
Drug intolerance (20)
Erythema (18)
Adverse drug reaction (17)
Application site exfoliation (17)
Application site vesicles (14)
Application site pain (12)
Application site dryness (10)
Application site pruritus (9)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TIRBANIBULIN Alternatives Have Lower Off label use Risk?
TIRBANIBULIN vs TIROFIBAN
TIRBANIBULIN vs TIRZEPATIDE
TIRBANIBULIN vs TISAGENLECLEUCEL
TIRBANIBULIN vs TISLELIZUMAB
TIRBANIBULIN vs TISOTUMAB VEDOTIN